Trial failure throws future of pharma into doubt

Paradigm Biopharmaceuticals has gone into voluntary administration as it seeks to find a path to viability after the catastrophic failure of its flagship Phase 3 trial.

To see the whole article, log in or create an account.

James Quintana Pearce